Reducing Chinese API Imports Key For Indian Pharma Growth, Says IPA
IPA Lays Out ‘Vision 2030’ For Indian Pharma Sector
The Indian government has formulated policy to reduce import dependence of APIs from China. The Indian Pharmaceutical Alliance lays out ‘Vision 2030,’ that aims to make the Indian pharma sector, the “world’s largest supplier of drugs by volume.”
